Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3420908 | 1.00 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL26363949 | 1.00 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL21373942 | 1.00 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL26664442 | 0.95 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL27230054 | 0.95 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL10015522 | 0.95 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL11919877 | 0.95 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL19448719 | 0.95 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL18031717 | 0.92 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL12404110 | 0.92 | TSHR (0.60) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638916-A1 | PROCESS FOR THE PRODUCTION OF ESTERS FROM EPOXIDES | Johnson & Johnson Vision Care, Inc. (US) | 2006-03-29 | — | — | EP | claimed |
| US-6933401-B2 | Process for the production of vicinal diesters from epoxides | JOHNSON & JOHNSON VISION CARE, INC. | 2005-08-23 | — | — | US | claimed |
| WO-2005005368-A1 | PROCESS FOR THE PRODUCTION OF ESTERS FROM EPOXIDES | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2005-01-20 | — | — | WO | claimed |
| US-20040267046-A1 | Process for the production of vicinal diesters from epoxides | JOHNSON & JOHNSON VISION CARE, INC. | 2004-12-30 | — | — | US | claimed |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| WO-2025030029-A1 | BRUSH POLYMER MACROMOLECULE STRUCTURES AND METHODS FOR DETECTING BIOMOLECULES | SEER, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| WO-2024071133-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2023224118-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2023-11-23 | — | — | WO | disclosed |
| WO-2022202498-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203042-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022102626-A1 | ULTRAVIOLET RAY CURABLE COMPOSITION AND APPLICATIONS THEREOF | ダウ・東レ株式会社 | 2022-05-19 | — | — | WO | disclosed |
| US-10023751-B2 | Anti-smudge and anti-graffiti compositions | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2018-07-17 | — | — | US | disclosed |
| US-5854147-A | Non-woven web containing antimicrobial siloxane quaternary ammonium salts | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| US-5777010-A | BLEND WITH THERMOPLASTIC POLYOLEFIN | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0760821-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1997-03-12 | — | — | EP | disclosed |
| US-5569732-A | TRISILOXANE | KIMBERLY-CLARK CORPORATION (US) | 1996-10-29 | — | — | US | disclosed |
| US-5567372-A | Method for preparing a nonwoven web containing antimicrobial siloxane quaternary ammonium salts | KIMBERLY-CLARK CORPORATION (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0702686-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1996-03-27 | — | — | EP | disclosed |
| WO-1995032977-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1995-12-07 | — | — | WO | disclosed |
| WO-1994029325-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267046-A1 | Process for the production of vicinal diesters from epoxides | DECR1, EPHX2, DHCR7 | TSHR 4839/4885SMN1; SMN2 3275/4885ALDH1A1 843/4885 |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | IDUA, SEM1, ARSA | TSHR 2587/4885SMN1; SMN2 361/4885ALDH1A1 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.